Listed by the USPTO as COBANOGLU, DILEK B
Tech Center 3600 • Art Units: 3626 3627 3683 3686 3687
This examiner grants 33% of resolved cases
COBANOGLU, DILEK B is assigned to tech center 3600 and art unit 3626. The profile records 509 resolved cases, with an allowance rate of 33.2%. The median time to allowance is 1602 days, so applicants should account for a lengthy prosecution interval when developing portfolio timing expectations.
The interview lift is 27.4%, indicating a positive association between interviews and allowance outcomes despite the lower allowance rate in the overall record. The listed companies are Cerner Innovation Inc., Biotronik SE & Co. KG, and KPN Innovations LLC. The recurring firms are Invoke, BUCHANAN INGERSOLL & ROONEY PC, and CALDWELL LLC. The substantial case volume makes the profile useful for historical benchmarking, but application-specific rejection analysis remains necessary before drawing a prosecution recommendation.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19040945 | ENVIRONMENTAL INFORMATION COLLECTION DEVICE, ENVIRONMENTAL INFORMATION COLLECTION METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 17613774 | METHODS AND APPARATUS FOR GENERATING A GRAPHICAL REPRESENTATION | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 19474449 | Peripheral artery disease step counter | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18553643 | Medical Support System and Medical Support Method for Patient Treatment | Final Rejection | BIOTRONIK SE & Co. KG |
| 18714365 | METHOD FOR CLASSIFYING A MEDICAL DEVICE AND/OR DRUG, SYSTEM AND TRAINING METHOD | Non-Final OA | BIOTRONIK AG |
| 17931293 | SYSTEMS AND METHODS FOR END-TO-END PET CARE TRANSACTIONS WEB PLATFORM | Non-Final OA | Mars, Incorporated |
| 18938009 | SYSTEM AND METHOD FOR MODIFYING A NUTRITION REQUIREMENT | Final Rejection | KPN INNOVATIONS LLC |
| 18521997 | APPARATUS AND METHOD FOR OUTPUTTING AN ALIMENTARY PROGRAM TO A USER | Non-Final OA | KPN INNOVATIONS, LLC. |
| 18439997 | MEDICAL DEVICE FOR ESTIMATING RISK OF PATIENT DETERIORATION | Non-Final OA | ZOLL Medical Corporation |
| 19222755 | MEDICANT DELIVERY SYSTEM, METHODS OF PROVIDING RECOMMENDATIONS REGARDING MEDICANT DELIVERY, AND RELATED SYSTEMS AND METHODS | Final Rejection | Insulet Corporation |
| 17150372 | INTELLIGENT SITUATIONAL ALARMS AND NOTIFICATIONS FOR DIABETES MANAGEMENT DEVICES | Non-Final OA | Insulet Corporation |
| 19026246 | Integrated Coordination Of Care | Final Rejection | Cerner Innovation, Inc. |
| 19026234 | Integrated Coordination Of Care | Final Rejection | Cerner Innovation, Inc. |
| 18767726 | Integrated Coordination Of Care | Non-Final OA | Cerner Innovation, Inc. |
| 18828556 | SYSTEMS AND METHODS FOR USING AI ML TO PREDICT, BASED ON DATA ANALYTICS OR BIG DATA, AN OPTIMAL NUMBER OR RANGE OF REHABILITATION SESSIONS FOR A USER | Final Rejection | ROM TECHNOLOGIES, INC. |
| 18235510 | METHOD FOR PREDICTING RISK OF DEPRESSION RELAPSE OR ONSET | Non-Final OA | IQVIA Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.2% of resolved applications examined by Dilek B Cobanoglu were allowed (509 resolved cases), compared with 24.9% across Art Unit 3626 over the last five years.
This examiner's interview lift is +27.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Dilek B Cobanoglu took 1,602 days on average from filing to allowance.
Dilek B Cobanoglu examines applications in Art Unit 3626 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).